Holyhead Pharmaceuticals Private Limited
About Holyhead Pharmaceuticals Private Limited
Data last updated:
Holyhead Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 17 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U74999OR2017PTC026744. Its GSTIN is 21AAECH1256N1ZO (Odisha). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sruti Ranjan Mishra and Shilpa Parag Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 101 Gymkhana Palm Height Shampur Ghatikia, Bhubaneswar, Odisha, India – 751003.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.53 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹99,060 (net margin 13.2%) and EBITDA of ₹1.1 Lakh (EBITDA margin 14.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Holyhead Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressD – 101 Gymkhana Palm Height Shampur Ghatikia, Bhubaneswar, Odisha, India – 751003
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Holyhead Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Holyhead Pharmaceuticals Private Limited
FY 2025 filings availableHolyhead Pharmaceuticals Private Limited reported revenue of ₹7.53 Lakh (up 5757% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹99,060 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | ||||
| Net Profit Margin | 13.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Holyhead Pharmaceuticals Private Limited, buy the company report.
Board of directors of Holyhead Pharmaceuticals Private Limited
Holyhead Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sruti Ranjan Mishra Also directs: Pharmaviz Private Limited, Tatwa Technologies Limited | Director | 17 Mar 2017 | 9 Years 7 Months | Current |
| Shilpa Parag Das Also directs: Rissop Natural Foods & Medicinal Products LLP | Director | 17 Mar 2017 | 9 Years 7 Months | Current |
| Snigdha Mishra Also directs: Orivest Enterprises Private Limited | Director | 17 Mar 2017 | 9 Years 7 Months | Current |
| Puspalata Mishra | Director | 17 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Holyhead Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Impac Pharmaceuticals Private Limited | ₹7.57 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Eden Tulip Pharmaceuticals Private Limited | ₹7.56 Lakh (FY 2018) | 9.0% | Delhi, India | |||
| Eosin Pharmaceuticals Private Limited | ₹7.55 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Adreno Pharmaceuticals Private Limited | ₹7.54 Lakh (FY 2025) | -24.0% | Rohini New, Delhi, India | |||
| Yajas Pharmaceuticals Private Limited | ₹7.53 Lakh (FY 2024) | 161.0% | Palghar, Maharashtra, India | |||
| Holyhead Pharmaceuticals Private Limitedthis company | ₹7.53 Lakh (FY 2025) | ₹99,060 | 13.2% | 5757.0% | Bhubaneswar, Odisha, India | |
| Vitanook Pharmaceuticals Private Limited | ₹7.53 Lakh (FY 2024) | Delhi, India | ||||
| Proethic Pharmaceuticals Private Limited | ₹7.53 Lakh (FY 2025) | -20.0% | Delhi, India | |||
| Erdster Pharmaceuticals Private Limited | ₹7.52 Lakh (FY 2024) | Hazratganj, Uttar Pradesh, India | ||||
| Jacob Pharmaceuticals Private Limited | ₹7.52 Lakh (FY 2024) | -58.0% | Madurai, Tamil Nadu, India | |||
| Dr.Madhukar Pharmaceuticals Private Limited | ₹7.51 Lakh (FY 2024) | Thane, Maharashtra, India |
To see the full peer comparison of Holyhead Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Holyhead Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Holyhead Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Holyhead Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAECH1256N1ZO | Odisha | Active | 12 Oct 2017 |
| 24AAECH1256N1ZI | Gujarat | Active | 16 Jun 2020 |
To see the full GST registrations and return filing status of Holyhead Pharmaceuticals Private Limited, buy the company report.
Recent activity
Holyhead Pharmaceuticals Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Puspalata Mishra was appointed as Director on 17 Mar 2017.
Frequently asked questions
Holyhead Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in other services, within the business services industry. It was incorporated on 17 March 2017 (9+ years old) and is registered under CIN U74999OR2017PTC026744.
Holyhead Pharmaceuticals has 4 current directors:
- Sruti Ranjan Mishra - Director
- Shilpa Parag Das - Director
- Snigdha Mishra - Director
- Puspalata Mishra - Director
The latest financial statements of Holyhead Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Holyhead Pharmaceuticals is 21AAECH1256N1ZO, registered in Odisha. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAECH1256N1ZI (Gujarat).
The CIN (Corporate Identification Number) of Holyhead Pharmaceuticals is U74999OR2017PTC026744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Holyhead Pharmaceuticals was incorporated on 17 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Holyhead Pharmaceuticals by revenue are Impac Pharmaceuticals Private Limited, Eden Tulip Pharmaceuticals Private Limited, Eosin Pharmaceuticals Private Limited, Adreno Pharmaceuticals Private Limited, Yajas Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Puspalata Mishra was appointed as Director on 17 Mar 2017. Shilpa Parag Das was appointed as Director on 17 Mar 2017. Snigdha Mishra was appointed as Director on 17 Mar 2017. Holyhead Pharmaceuticals has 4 board changes on record in total.
The registered office of Holyhead Pharmaceuticals is at D – 101 Gymkhana Palm Height Shampur Ghatikia, Bhubaneswar, Odisha, India – 751003.
Holyhead Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Holyhead Pharmaceuticals is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.